title: [New tools for preventing and evaluating risk practices for hepatitis C transmission among injection drug users: some reflections on injection rooms and the measurement of risk-taking behaviors].
abstract: Injection rooms should be able to contribute to the prevention of the risks of transmission of hepatitis C (HCV) among intravenous drug users (IDUs). However, these services have yet to be set up and tested in France. This article presents a literature review of injection rooms and explores possible ways of evaluating the effects of this type of service on risks for HCV. Given the difficulties of estimating the service's impact on the incidence of HCV, evaluations could target injection-related risk taking behaviors. The second part of the article addresses the issue of risk taking practices and presents a new research tool able to explore out-of-the-ordinary situations involving risk-taking. Tested on a population of IDUs in Marseille, this tool detects forms of risk-taking and contexts in which injection is performed, which are always missed by the usual measures of risk practices. It could therefore be added to these measures and be useful for evaluating injection rooms.
authors.affiliation: Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur.
authors.forename: S
authors.initials: S
authors.lastname: Aubisson
authors.forename: P
authors.initials: P
authors.lastname: Carrieri
authors.forename: A M
authors.initials: AM
authors.lastname: Lovell
authors.forename: M K
authors.initials: MK
authors.lastname: Ben Diane
authors.forename: P
authors.initials: P
authors.lastname: Peretti-Watel
authors.forename: B
authors.initials: B
authors.lastname: Spire
mesh_terms: D000328:Adult; D003625:Data Collection; D005260:Female; D005602:France; D006266:Health Education / Q000379:methods*; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission*; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D015994:Incidence; D008297:Male; D016485:Needle Sharing; D018671:Needle-Exchange Programs; D015995:Prevalence; D012307:Risk Factors; D012309:Risk-Taking; D012494:Sampling Studies; D015819:Substance Abuse, Intravenous / Q000150:complications*; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D018937:Hepatitis C Antibodies